29.03.2022 - CHICAGO and TORONTO, March 29, 2022 (GLOBE NEWSWIRE) - Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new .